Peter Svensson
81 – 90 of 146
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.
- Contribution to journal › Article
-
Mark
Mechanical heart valve prosthesis and warfarin - Treatment quality and prognosis.
- Contribution to journal › Article
-
Mark
The association between red cell distribution width and venous thromboembolism: A biochemical evaluation
- Contribution to journal › Letter
- 2013
-
Mark
Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses
- Contribution to journal › Article
-
Mark
APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.
- Contribution to journal › Article
-
Mark
Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up.
- Contribution to journal › Article
-
Mark
Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
- Contribution to journal › Article
-
Mark
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
- Contribution to journal › Article
-
Mark
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
- Contribution to journal › Letter
-
Mark
Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
- Contribution to journal › Article
